These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33293430)

  • 1.
    Fowler JS
    J Nucl Med; 2020 Dec; 61(Suppl 2):105S-106S. PubMed ID: 33293430
    [No Abstract]   [Full Text] [Related]  

  • 2. Brookhaven Lab named historic chemical landmark.
    J Nucl Med; 2012 Dec; 53(12):12N. PubMed ID: 23203248
    [No Abstract]   [Full Text] [Related]  

  • 3. Renaissance of (18)F-FDG positron emission tomography in the imaging of pheochromocytoma/paraganglioma.
    Taïeb D; Timmers HJ; Shulkin BL; Pacak K
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2337-9. PubMed ID: 24878044
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and evaluation of an N-[
    Wu Z; Ma J; Brownell AL; Wang H; Li C; Meng X; Yuan L; Liu H; Li S; Xie J
    Nucl Med Biol; 2018 Nov; 66():40-48. PubMed ID: 30248568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging I.
    Alavi A
    Radiol Clin North Am; 2004 Nov; 42(6):xi-xiii. PubMed ID: 15488552
    [No Abstract]   [Full Text] [Related]  

  • 6. On the Origin of Hybrid Imaging.
    Lammertsma AA
    J Nucl Med; 2020 Dec; 61(Suppl 2):166S-167S. PubMed ID: 33293437
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel synthesis and initial preclinical evaluation of (18)F-[FDG] labeled rhodamine: a potential PET myocardial perfusion imaging agent.
    AlJammaz I; Al-Otaibi B; AlHindas H; Okarvi SM
    Nucl Med Biol; 2015 Oct; 42(10):804-8. PubMed ID: 26160144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [
    Rizzo-Padoin N; Chaussard M; Vignal N; Kotula E; Tsoupko-Sitnikov V; Vaz S; Hontonnou F; Liu WQ; Poyet JL; Vidal M; Merlet P; Hosten B; Sarda-Mantel L
    Nucl Med Biol; 2016 Dec; 43(12):773-780. PubMed ID: 27693672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of the positron-emitting radiotracer [(18)F]-2-fluoro-2-deoxy-D-glucose from resin-bound perfluoroalkylsulfonates.
    Brown LJ; Ma N; Bouvet DR; Champion S; Gibson AM; Hu Y; Jackson A; Khan I; Millot N; Topley AC; Wadsworth H; Wynn D; Brown RC
    Org Biomol Chem; 2009 Feb; 7(3):564-75. PubMed ID: 19156324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective use of a new quality and safety checklist for the steady and safe supply of fluorine-18 fluorodeoxyglucose for positron emission tomography/computed tomography.
    Kawabata Y; Maruyama I; Tanaka K; Taniyama T
    Hell J Nucl Med; 2012; 15(2):130-3. PubMed ID: 22833859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Historic images in nuclear medicine: 1976: the first issue of clinical nuclear medicine and the first human FDG study.
    Hess S; Høilund-Carlsen PF; Alavi A
    Clin Nucl Med; 2014 Aug; 39(8):701-3. PubMed ID: 24978339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated synthesis of N-(2-[
    Liu S; Sun A; Zhang Z; Tang X; Nie D; Ma H; Jiang S; Tang G
    J Labelled Comp Radiopharm; 2017 Jun; 60(7):331-336. PubMed ID: 28370543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of nuclear medicine and the musculoskeletal system.
    Palestro CJ; Love C; Schneider R
    Radiol Clin North Am; 2009 May; 47(3):505-32. PubMed ID: 19361673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Basic Principles of FDG-PET/CT Imaging.
    Basu S; Hess S; Nielsen Braad PE; Olsen BB; Inglev S; Høilund-Carlsen PF
    PET Clin; 2014 Oct; 9(4):355-70, v. PubMed ID: 26050942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and experimental medicine applications of PET in oncology: a historical perspective.
    Jones T; Price P
    Lancet Oncol; 2012 Mar; 13(3):e116-25. PubMed ID: 22381934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.
    McLarty K; Moran MD; Scollard DA; Chan C; Sabha N; Mukherjee J; Guha A; McLaurin J; Nitz M; Houle S; Wilson AA; Reilly RM; Vasdev N
    Nucl Med Biol; 2011 Oct; 38(7):953-9. PubMed ID: 21982567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of radioactive waste gases from PET radiopharmaceutical synthesis using cost effective capture systems integrated with a cyclotron safety system.
    Stimson DH; Pringle AJ; Maillet D; King AR; Nevin ST; Venkatachalam TK; Reutens DC; Bhalla R
    J Radiol Prot; 2016 Sep; 36(3):504-517. PubMed ID: 27383139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caged [(18)F]FDG Glycosylamines for Imaging Acidic Tumor Microenvironments Using Positron Emission Tomography.
    Flavell RR; Truillet C; Regan MK; Ganguly T; Blecha JE; Kurhanewicz J; VanBrocklin HF; Keshari KR; Chang CJ; Evans MJ; Wilson DM
    Bioconjug Chem; 2016 Jan; 27(1):170-8. PubMed ID: 26649808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on "Positron Emission Tomography in the Lung" 25 years after publication in the inaugural issue of the Journal of Thoracic Imaging.
    Patz EF; Erasmus JJ
    J Thorac Imaging; 2010 Feb; 25(1):39-40. PubMed ID: 20160601
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative Cerebral Blood Flow with PET in the 1980s: Going with the Flow.
    Carson RE
    J Nucl Med; 2020 Dec; 61(Suppl 2):89S-90S. PubMed ID: 33293455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.